Lonza's leadership in powder-in-capsule (PIC) development using our Xcelodose™; precision powder micro-dosing systems technology spans more than 200 active pharmaceutical ingredients (APIs) and more than 600 batches. This micro-dosing platform and extensive expertise can help customers accelerate initial studies to determine if an API should be advanced for further investment and investigation. To learn more, please see our technical brief.
View our technical brief

Download now
Latest content
Latest briefing from the Knowledge Center